The global antibody drug conjugate (ADC) market is experiencing rapid growth driven by the rising prevalence of cancer, advancements in targeted therapy, and continuous innovation in antibody engineering and cytotoxic payload technologies. Valued at USD 12.70 billion in 2024, the market is projected to expand to USD 14.20 billion in 2025 and further reach USD 35.40 billion by 2032, registering...
The global Antibody Drug Conjugate market is a dynamic and promising industry that has shown significant growth in recent years. According to Extrapolates recent market study, the Antibody Drug Conjugate market was valued at USD 14.20 billion in 2024 and is expected to reach USD 35.40 billion by 2031, exhibiting a robust CAGR of 13.94% over the forecast period of 2024-2031. This report provides...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt